Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03934528

The Impact of a Virtual Reality Environment on Phantom Limb Pain

The Impact of Simulated Arm Movement Within a Virtual Reality Environment on Phantom Limb Pain in Upper Limb Amputees: A Pilot Study

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Manchester · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Phantom limb pain occurs in the majority of people who lose a limb. It significantly affects quality of life and is hard to manage. Recent evidence suggests that mirror therapy and similar techniques that create a visual representation of the missing limb under the control of the patient may reduce phantom limb pain. The investigators previously explored the use of a virtual reality environment for this purpose with people with upper limb loss but found that using it within the clinical setting limited its potential efficacy. Phantom limb pain is highly variable and assessing the effects of the activity during a hospital appointment when the phantom pain may not be present, or may not be problematic, made it difficult to judge the effects adequately. This study involves training the patient in the clinic to use a portable, self-contained virtual reality system which they will then use at home, unsupervised, for 2 months. The aim is to discover whether phantom limb pain intensity decreases by performing an activity in a virtual reality environment in which a visual representation of the missing limb is controlled by the patient. Participants will be directed to use the system every day, and whenever their phantom limb pain is present and problematic.

Conditions

Interventions

TypeNameDescription
DEVICEVirtual environment activityPatients undertake an activity using simulated arm movement within a virtual reality environment every day for two months

Timeline

Start date
2019-06-01
Primary completion
2019-09-01
Completion
2019-11-01
First posted
2019-05-02
Last updated
2025-04-30

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03934528. Inclusion in this directory is not an endorsement.